Actemra 160mg, a drug known scientifically as tocilizumab, is a a potent biologic agent primarily employed for the control of rheumatoid arthritis. This effective substance website operates by interfering with the activity of interleukin-6 (IL-6), a signaling protein crucial in the inflammatory process. Additionally, Actemra has shown efficacy in